Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China YCT International Group, Inc., which rebranded as Spring Pharmaceutical Group, Inc. in 2018, is a healthcare and biotechnology company headquartered in Sishui County, Shandong Province, China. Established in 1989, the company specializes in the research, development, and commercialization of traditional Chinese medicines (TCM), nutraceuticals, and health supplements. Its core product offerings include the Huoliyuan (Vitality Source) capsule, ginkgo-based herbal teas, and products derived from Acer truncatum bunge (Purpleblow Maple) seed oil. The company is vertically integrated, managing its own planting bases for raw materials through its subsidiary, Shandong Spring Pharmaceutical, to ensure quality and supply consistency. China YCT's portfolio targets a range of conditions including immune system support, infectious diseases like influenza, and chronic metabolic disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China YCT International.